Lexpos News

From 1 November 2023, the list of medicines covered by the HRT prepayment certificate (HRT PPC) will be updated to include a new brand of progesterone micronised capsules, Gepretix®. Part XVI of the November 2023 Drug Tariff will be updated to include the following new HRT medicine for which patients will be able to purchase an [...]

The post Gepretix® added to the HRT PPC medicines list from November 2023 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/10/2023) announced the following final list of price concessions for October 2023: Drug Pack size Price concession Atomoxetine 10mg capsules 28 £45.59 Amisulpride 200mg tablets 60 £31.19 Betahistine 16mg [...]

The post October 2023 Price Concessions – Final Update appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 3 October 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age MedSafetyWeek November 2023: your Yellow Card report helps [...]

The post MHRA Drug Safety Update: October 2023 appeared first on Community Pharmacy England.

Pharmacy Press As today marks the beginning of Ask Your Pharmacist Week (October 30th to November 6th), the National Pharmacy Association (NPA) has also released survey data highlighting that more people in England are embracing community pharmacies as key healthcare settings. This polling data supports the wider efforts to promote the crucial role of pharmacies [...]

The post #AskYourPharmacistWeek: NPA data highlights public appreciation of Community Pharmacy appeared first on Community Pharmacy England.

The Sunday Times  The supply issues for ADHD medicines have intensified alongside a significant increase in patient demand. The situation presents as a growing challenge for community pharmacies that are unable to obtain stock. Additionally, GPs are also having to refer patients back to specialist clinics for dose adjustments, which is leading to delays in [...]

The post ADHD diagnoses surge amid escalating medicine supply challenges appeared first on Community Pharmacy England.